Pure Global

A study in people with cystic fibrosis (a rare pulmonary disease) to assess the pharmacokinetics and safety of a combination of two experimental drugs" - Trial 2017-001078-41

Access comprehensive clinical trial information for 2017-001078-41 through Pure Global AI's free database. This phase not specified trial is sponsored by Vertex Pharmaceuticals Incorporated and is currently status unknown. The study focuses on Cystic Fibrosis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
2017-001078-41
Trial Details
EU Clinical Trials Register • 2017-001078-41
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A study in people with cystic fibrosis (a rare pulmonary disease) to assess the pharmacokinetics and safety of a combination of two experimental drugs"

Study Focus

Cystic Fibrosis

Sponsor & Location

Vertex Pharmaceuticals Incorporated

Timeline & Enrollment

N/A

N/A

N/A

Primary Outcome

•History of any illness or condition that might confound the results of the study or pose an additional risk in administering study drug to the subject

ICD-10 Classifications

Family history of congenital malformations, deformations and chromosomal abnormalities
Congenital malformations, deformations and chromosomal abnormalities
Other specified congenital malformations
Special screening examination for congenital malformations, deformations and chromosomal abnormalities
Personal history of congenital malformations, deformations and chromosomal abnormalities

Data Source

EU Clinical Trials Register

2017-001078-41

Non-Device Trial